PLS Plantations PAT up by 109.6%
Concludes FY2022 on a high note with consistent performance across key indicators compared to the preceding year Key Financial and
Read More
revenue
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue
Group’s financial performance supported by higher margin and contribution from biopharmaceutical business Malaysian Genomics Resource Centre Berhad, a leading genomics
Read More